AMRC advocates for the benefits of the multisite clinical research corporation (MCRC) model. Our research, reports, and working groups give sponsors, CROs, regulators, and policymakers solutions and insight to help improve clinical research speed, efficiency, and patient outcomes.
A practical guide to the operational infrastructure modern MCRCs run on and the data capabilities that stack facilitates.
In this spirited roundtable discussion, leading clinical trial experts will debate how PE’s impact quality at sites.
Working together to define and recognize quality in clinical research.
AMRC’s advocacy goals for 2026 and why we're focused on getting MCRC performance recognized as evidence of quality.
Findings of AMRC's industry consultation. What sponsors, CROs and multisite organizations told us about how quality is defined and assessed in practice.
AMRC’s 2025 research, run in collaboration with SBM Research, investigates how Sponsors and CROs perceive MCRCs performance.
